by Li Yuan, Chinese Academy of Sciences Epilepsy is a central nervous system disorder characterized by recurrent seizures resulting from excessive excitation or inadequate inhibition of neurons. Ultrasound stimulation has recently emerged as a noninvasive method for modulating brain activity; however, its range and effectiveness for different neurological disorders, such as Parkinson Disease, Epilepsy and...
Researchers of Sechenov University, a Project 5-100 participant, together with their colleagues from Australia used the microfluidics technology to develop a device able to isolate cancer cells from urine of patients with prostate cancer. The study showed high sensitivity and specificity of the new method in diagnosing prostate cancer. The results obtained were published in...
UNIVERSITY OF MICHIGAN ANN ARBOR–Invasive procedures to biopsy tissue from cancer-tainted organs could be replaced by simply taking samples from a tiny “decoy” implanted just beneath the skin, University of Michigan researchers have demonstrated in mice. These devices have a knack for attracting cancer cells traveling through the body. In fact, they can even pick...
CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) When the surgeon surgically removes a melanoma, some patients are said to be ‘cancer-free’ and they do not get additional treatment. However, should the fluid obtained in the drainage implanted after surgery be tested using the liquid biopsy technique rather than be disposed of as medical waste, the test might predict the high or...
Highlights: Genetron Health (Beijing) Co. Ltd and National Cancer Center/ Cancer Hospital, Chinese Academy of Medical Sciences published the promising results of their liver cancer early screening study using cell free DNA and protein biomarkers. This product for screening HCC in at-risk populations, will be further validated and then available for use. This methodology is expected to be applied in early screening of other cancer types. March 12th, 2019, Beijing – Today, Proceedings of...
Biopsies are a necessary burden for people with cancer. Taking a small sample of tissue and sending it through genetic and molecular analysis can help doctors not just diagnose cancer, but also learn more about its inner workings to find the best treatments based on which mutations are feeding the disease. But tissue biopsies are...
Researchers have launched a clinical trial to develop a breath test, analysing molecules that could indicate the presence of cancer at an early stage. This is the first test of its kind to investigate multiple cancer types. A cancer breath test has huge potential to provide a non-invasive look into what’s happening in the body and could help to find cancer early when treatment is more likely to be...
In one of the largest clinical studies to ever examine the impact of using a blood test to detect treatable mutations in non-small cell lung cancer (NSCLC), researchers from the Abramson Cancer Center of the University of Pennsylvania found that they could identify significantly more mutations through liquid biopsy instead of a solid tissue biopsy alone. The findings also show that patients whose actionable mutations were detected by the blood-based liquid biopsy responded favorably to targeted therapies. Overall,...
A new liquid biopsy test could detect cancer years before symptoms are apparent, according to research presented today (June 1) at the American Society of Clinical Oncologists (ASCO) meeting in Chicago. The test—a noninvasive blood draw followed by DNA screening—could lead to dramatic changes in cancer treatment, say researchers. “This is potentially the holy grail of cancer...
New technique developed at Washington University in St. Louis uses blood test Taking a biopsy of a brain tumor is a complicated and invasive surgical process, but a team of researchers at Washington University in St. Louis is developing a way that allows them to detect tumor biomarkers through a simple blood test. IMAGE: A TEAM OF ENGINEERS...
